Research.Patient.info
Non resectable Hepatocellular carcinoma (HCC) research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
Clinical investigation evaluating safety and efficacy of selective intra-arterial 166Holmium radiation therapy in combination with atezolizumab and bevacizumab for non resectable Hepatocellular carcinoma (HOLMBRAVE)
This study is looking at a new way to treat liver cancer that can't be removed by surgery. It combines radiation therapy directly to the liver with two medicines, atezolizumab and bevacizumab, to see if this treatment is safe and effective in shrinking tumors.
France - ongoing, recruitingPhase I and Phase II (Integrated)- Other
Study of the benefit of lenvatinib treatment in waiting list of liver transplantation after TACE failure in patients with hepatocellular carcinoma (HCC) : Ta-Len-Tra
This study is looking at how a medicine called lenvatinib helps people with a type of liver cancer who are waiting for a liver transplant after other treatments haven't worked. It checks if taking lenvatinib helps them get to a transplant and how safe it is.
France